Clinical applications of heart rhythm monitoring tools in symptomatic patients and for screening in high-risk groups

Europace. 2022 Nov 22;24(11):1721-1729. doi: 10.1093/europace/euac088.

Abstract

Recent technological advances have facilitated and diversified the options available for the diagnosis of cardiac arrhythmias. Ranging from simple resting or exercise electrocardiograms to more sophisticated and expensive smartphones and implantable cardiac monitors. These tests and devices may be used for varying periods of time depending on symptom frequency. The choice of the most appropriate heart rhythm test should be guided by clinical evaluation and optimized following accurate characterization of underlying symptoms, 'red flags', risk factors, and consideration of cost-effectiveness of the different tests. This review provides evidence-based guidance for assessing suspected arrhythmia in patients who present with symptoms or in the context of screening, such as atrial fibrillation or advanced conduction disturbances following transcatheter aortic valve implantation in high-risk groups. This is intended to help clinicians choose the most appropriate diagnostic tool to facilitate the management of patients with suspected arrhythmias.

Keywords: Atrial fibrillation; ECG monitoring; Holter; Implantable cardiac monitors; Palpitations; Syncope; TAVI.

Publication types

  • Review

MeSH terms

  • Atrial Fibrillation* / diagnosis
  • Electrocardiography*
  • Exercise Test
  • Humans
  • Mass Screening
  • Smartphone